Do not admix with other drugs.
DESCRIPTION
Lidocaine Hydrochloride and 5% Dextrose Injection USP is a sterile, nonpyrogenic solution prepared from lidocaine hydrochloride and dextrose in water for injection.
Lidocaine hydrochloride is designated chemically as 2-(Diethylamino)-2',6'-acetoxylidide monohydrochloride. The solution serves as a cardiac antiarrhythmic agent intended for intravenous use.
Composition - Each 100 mL contains: | Solution | Lidocaine
Hydrochloride
Anhydrous
USP | Hydrous
Dextrose
USP | pH | Calculated
Osmolarity
mOsmol/liter |
|---|
0.2% Lidocaine HCl and
5% Dextrose Injection USP | 0.2 g | 5 g | 4.4 (3.0–7.0) | 265 |
0.4% Lidocaine HCl and
5% Dextrose Injection USP | 0.4 g | 5 g | 4.4 (3.0–7.0) | 280 |
0.8% Lidocaine HCl and
5% Dextrose Injection USP | 0.8 g | 5 g | 4.2 (3.0–7.0) | 305 |
Water for Injection USP qs
The formulas of the active ingredients are:
Lidocaine Hydrochloride Anhydrous USP
(M.W. 270.80) | 
Hydrous Dextrose USP
(M.W. 198.17) |
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a tamper evident plastic protector. Refer to the Directions for Use of the container.
